홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Methanol → 2-Amino-1-(4-(6-(2-aminobenzo[d]oxazol-5-yl)-1,5-naphthyridin-3-yl)piperazin-1-yl)-2-methylpropan-1-one

HRID 509646
노트
인쇄 미리보기

반응식

HRID 509646 반응식
C(Cl)(=O)C.CO.C(OC(=O)[NH:13][C:14]([CH3:44])([CH3:43])[C:15]([N:17]1[CH2:22][CH2:21][N:20]([C:23]2[CH:24]=[N:25][C:26]3[C:31]([CH:32]=2)=[N:30][C:29]([C:33]2[CH:34]=[CH:35][C:36]4[O:40][C:39]([NH2:41])=[N:38][C:37]=4[CH:42]=2)=[CH:28][CH:27]=3)[CH2:19][CH2:18]1)=[O:16])(C)(C)C.C([O-])([O-])=O.[Na+].[Na+]>O>[NH2:13][C:14]([CH3:44])([CH3:43])[C:15]([N:17]1[CH2:22][CH2:21][N:20]([C:23]2[CH:24]=[N:25][C:26]3[C:31]([CH:32]=2)=[N:30][C:29]([C:33]2[CH:34]=[CH:35][C:36]4[O:40][C:39]([NH2:41])=[N:38][C:37]=4[CH:42]=2)=[CH:28][CH:27]=3)[CH2:19][CH2:18]1)=[O:16]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 887MethanolHCID 6367Acetyl chlorideHCID 10340Sodium CarbonateHCID 70648853Tert-butyl(1-(4-(6-(2-aminobenzo[d]oxazol-5-yl)-1,5-naphthyridin-3-yl)piperazin-1-yl)-2-methyl-1-oxopropan-2-yl)carbamate

생성물 1

HCID 546753802-Amino-1-(4-(6-(2-aminobenzo[d]oxazol-5-yl)-1,5-naphthyridin-3-yl)piperazin-1-yl)-2-methylpropan-1-one수율 62.3%

시약·촉매·용매 1

HCID 962Water용매

반응 조건

온도
0 °C

실험 절차

Acetyl chloride (4.3 mL, 60.5 mmol) was added to MeOH (11 mL) at 0° C., the resulting solution was stirred at 0° C. for 30 min. To this solution, tert-butyl(1-(4-(6-(2-aminobenzo[d]oxazol-5-yl)-1,5-naphthyridin-3-yl)piperazin-1-yl)-2-methyl-1-oxopropan-2-yl)carbamate (D-21) (85 mg, 0.16 mmol, 1.0 eq) was added, and the mixture was stirred at RT for 2 h. The reaction was complete based on TLC analysis. The mixture was diluted with water (20 mL), neutralized with solid Na2CO3 (about 3.5 g) to adjust pH value to 8-9, and extracted with CH2Cl2 (6×30 mL). The combined organic layer was dried over Na2SO4 and filtered. The filtrate was concentrated in vacuo and purified by silica gel column chromatography (11% MeOH/CH2Cl2) to afford the desired product, 2-amino-1-(4-(6-(2-aminobenzo[d]oxazol-5-yl)-1,5-naphthyridin-3-yl)piperazin-1-yl)-2-methylpropan-1-one (43) (43 mg, 62.3%) as a yellow solid. 1H NMR (400 MHz, DMSO-d6) δ: 8.96 (s, 1H), 8.28 (d, J=8.8 Hz, 1H), 8.12-8.09 (m, 2H), 7.92 (d, J=7.6 Hz, 1H), 7.59 (s, 1H), 7.60-7.47 (m, 3H), 4.01 (m, 4H), 3.42 (m, 4H), 1.347 (s, 6H); ESI-MS m/z: 432.21 [M+H]+.

후처리

  1. stirringthe mixture was stirred at RT for 2 h
  2. extractionextracted with CH2Cl2 (6×30 mL)
  3. dry with materialThe combined organic layer was dried over Na2SO4
  4. filtrationfiltered
  5. concentrationThe filtrate was concentrated in vacuo
  6. custompurified by silica gel column chromatography (11% MeOH/CH2Cl2)

출처 및 근거

ORD 기록
ord-b5d462959a674eada0fb9d44072345de
출처 데이터셋
uspto-grants-2015_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09096590B2

반응 노트

불러오는 중…

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트